Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

116
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
116
Biostatistics: Overview01:20

Biostatistics: Overview

611
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
611
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

454
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
454
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

307
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
307
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

102
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
102
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

137
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
137

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Combination of Compound Heterozygous Variants in IFNGR1 Causing Complete IFNGR1 Deficiency.

Journal of clinical immunology·2024
Same author

Harnessing student involvement: Perspectives from building infrastructure for sexual harassment prevention and response at the University of Lagos, Nigeria.

Journal of global health·2022
Same author

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies.

mAbs·2022
Same author

A comparison of statistical methods for animal oncology studies.

Pharmaceutical statistics·2022
Same author

CNS TB-IRIS Following Cessation of Adalimumab in an Adolescent With Crohn's Disease.

Open forum infectious diseases·2022
Same author

Impact of the COVID-19 pandemic on global health research training and education.

Journal of global health·2020

Related Experiment Video

Updated: Dec 11, 2025

A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System
13:22

A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System

Published on: September 10, 2013

12.3K

A Bayesian Statistical Approach to Continuous Qualification of a Bioassay.

Steven J Novick1, Elizabeth Christian2, Erika Farmer2

  • 1Department of Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD; and steven.novick@astrazeneca.com.

PDA Journal of Pharmaceutical Science and Technology
|August 21, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces continuous qualification for bioassays, using Bayesian methods to integrate historical data. This approach enhances confidence in bioassay accuracy and precision earlier in development.

Keywords:
AccuracyIntermediate precisionValidationVariance components

More Related Videos

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies
09:37

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies

Published on: January 19, 2022

6.8K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

398

Related Experiment Videos

Last Updated: Dec 11, 2025

A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System
13:22

A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System

Published on: September 10, 2013

12.3K
Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies
09:37

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies

Published on: January 19, 2022

6.8K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

398

Area of Science:

  • Biopharmaceutical development
  • Analytical chemistry
  • Statistical modeling

Background:

  • Validated bioassays are critical for measuring drug potency, requiring rigorous characterization of accuracy and precision.
  • Bioassay data is often generated across multiple studies (qualification, clinical phases, process development, technology transfer), typically reported independently.
  • Current practices may delay comprehensive assessment of bioassay performance until late-stage validation.

Purpose of the Study:

  • To propose and evaluate a novel approach for continuous characterization of bioassay accuracy and precision.
  • To leverage historical bioassay data for more robust performance assessment throughout the development lifecycle.
  • To enable earlier and more confident determination of bioassay suitability for commercial manufacturing.

Main Methods:

  • Implementation of a 'continuous qualification' strategy, starting from the initial bioassay qualification study.
  • Application of Bayesian statistical methods to integrate historical data, forming a prior knowledge base.
  • Blending prior knowledge with current study data to update assessments of accuracy and precision.
  • Utilizing the total-variance approach for constructing system suitability and control limits.

Main Results:

  • Continuous qualification allows for high-confidence assessment of bioassay accuracy and precision well before commercialization.
  • The Bayesian approach effectively incorporates historical data, leading to more informed and stable performance estimates.
  • The total-variance approach facilitates the robust development of system suitability and control limits for potency measurements.

Conclusions:

  • Continuous qualification offers a more efficient and data-rich approach to bioassay characterization compared to traditional independent reporting.
  • Bayesian statistical methods are well-suited for integrating historical data in bioassay development, enhancing predictive power.
  • This integrated strategy supports regulatory expectations and strengthens the foundation for reliable commercial bioassay performance.